Leting Zheng

发表

Transitional B cell cytokines predict renal allograft outcomes

D. Landsittel, A. Cherukuri, A. Salama, 2021, Science Translational Medicine.

B cell-activating factor and its targeted therapy in autoimmune diseases.

Jie Tian, Liwei Lu, F. Xiao, 2021, Cytokine & growth factor reviews.

B Cell IL-4 Drives Th2 Responses In Vivo, Ameliorates Allograft Rejection, and Promotes Allergic Airway Disease

V. Kuchroo, D. Rothstein, K. Mohib, 2022, Frontiers in Immunology.

Identification of immune-related diagnostic markers in primary Sjögren’s syndrome based on bioinformatics analysis

Wen Zeng, Jing Wen, Leting Zheng, 2022, Annals of translational medicine.

p53 predominantly regulates IL-6 production and suppresses synovial inflammation in fibroblast-like synoviocytes and adjuvant-induced arthritis

Juan Shi, Fengchun Zhang, D. Zheng, 2016, Arthritis Research & Therapy.

Interferon regulatory factor 1 (IRF-1) downregulates Checkpoint kinase 1 (CHK1) through miR-195 to upregulate apoptosis and PD-L1 expression in Hepatocellular carcinoma (HCC) cells

D. Geller, Q. Du, Ya-rong Guo, 2021, British Journal of Cancer.

Interferon regulatory factor 1 (IRF-1) and IRF-2 regulate PD-L1 expression in hepatocellular carcinoma (HCC) cells

D. Geller, B. Yan, Q. Du, 2020, Cancer Immunology, Immunotherapy.

Interferon regulatory factor 1(IRF-1) activates anti-tumor immunity via CXCL10/CXCR3 axis in hepatocellular carcinoma (HCC).

D. Geller, H. Yazdani, Q. Du, 2021, Cancer letters.

Effects of thalidomide on Th17, Treg cells and TGF‐β1/Smad3 pathway in a mouse model of systemic sclerosis

L. Lei, Cheng Zhao, Jing Wen, 2019, International journal of rheumatic diseases.

Tree shrews as a new animal model for systemic sclerosis research

L. Lei, Fang Qin, Leting Zheng, 2024, Frontiers in immunology.

Development and validation of a new diagnostic prediction model of ENHO and NOX4 for early diagnosis of systemic sclerosis

Leting Zheng, Wen Zeng, Shuyuan Chen, 2024, Frontiers in Immunology.